Aemetis (AMTX) Enters Licensing Agreement for Edeniq's Pathway Technology
- Wall Street ends week positively; S&P 500, Dow hit record highs
- Bitcoin (BTC) Drops 3% as Turkey Bans Cryptocurrency Payments Citing Lack of Regulatory Supervision
- Morgan Stanley (MS) Archegos-Related Loss Appears to be $911M
- Dollar at 4-week low on retreating Treasury yields
- J&J (JNJ) Privately Asked Rival Covid-19 Vaccine Makers to Inspect Clotting Risks, AstraZeneca (AZN) Said Yes but Pfizer (PFE) and Moderna (MRNA) Declined - Report
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
Edeniq, Inc., a biorefining and cellulosic technology company, and Aemetis, Inc. (NASDAQ: AMTX) announced they have entered into a License Agreement under which Aemetis will deploy Edeniq's Pathway technology at its 60 million gallon per year ethanol production facility located in Keyes, California.
Edeniq's Pathway Technology integrates Edeniq's Cellunator™ equipment with cellulase enzymes to convert corn kernel fiber to cellulosic ethanol. The Pathway Technology utilizes existing fermentation and distillation equipment to produce up to 2.5% cellulosic ethanol and a 7% increase in overall ethanol yield.
"We selected Edeniq's technology because we believe it is the fastest and most cost-efficient route to cellulosic ethanol," said Eric McAfee, Chairman and Chief Executive Officer of Aemetis. "This partnership is part of our commitment to being a leader in the transition toward advanced biofuel production in the United States and globally."
"Aemetis joins a growing list of customers that trust Edeniq to provide best-in-class technology solutions and services," said Brian Thome, President and CEO of Edeniq. "Our team is looking forward to working with the Aemetis team to integrate our technology into their facility."
Edeniq is the leader in developing analytical methods to quantify cellulosic ethanol co-produced with first-generation ethanol during fermentation, which is required to access regulatory value including D3 Renewable Identification Numbers (RINs). Aemetis plans to use Edeniq's methods to submit a registration to the U.S. Environmental Protection Agency for D3 RINs.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AAR Corp. (AIR) Reports Election of Ellen M. Lord to Board
- RealPage's (RP) to be halted April 21 ahead of closing of merger, says Nasdaq
- TG Therapeutics (TGTX) Announces Positive Results from the ULTIMATE I & II Phase 3 Trials of Ublituximab in MS to be Presented at American Academy of Neurology 73rd Annual Meeting
Create E-mail Alert Related CategoriesCorporate News, Management Comments
Related EntitiesDefinitive Agreement
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!